Krankheiten der Nagelwälle

Heller, Julius

doi:10.1007/978-3-642-91683-0_10

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only two studies found prevalence rates below 40Á0%. 12,22 The prevalences found in the remaining studies varied between 40% and 80%, and are in line with the result of the present study.…”

Section: Discussionsupporting

confidence: 92%

“…In the literature, percentages of patients with psoriasis with nail involvement vary between 10Á0% and 81Á8%. 4,[7][8][9][10]12,14,15,[20][21][22] Comparison of the different prevalence numbers of nail psoriasis found in different studies is difficult as a consequence of the different methodological designs. A design comparable with the present study was used in two studies.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Nail psoriasis: a questionnaire-based survey

2013

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Nail psoriasis: a questionnaire-based survey

2013

View full text Add to dashboard Cite

show abstract

“…Yellow nail syndrome (YNS) is a very rare disorder, probably first described by Heller [1], then, in 1964, by Samman and White [2] for a series of patients with yellow nails associated with lymphedema. YNS usually occurs around 50 years of age but pediatric or familial forms have been reported, albeit rarely, suggesting two different disease forms [3, 4].…”

Section: Introductionmentioning

confidence: 99%

Yellow Nail Syndrome: Analysis of 23 Consecutive Patients and Effect of Combined Fluconazole-Vitamin-E Treatment

Benassaia,

Abba,

Fourgeaud

et al. 2023

Dermatology

View full text Add to dashboard Cite

Background. Yellow nail syndrome (YNS), a very rare disorder of unknown etiology, is characterized by a triad associating yellow nails, respiratory manifestations and lymphedema. YNS treatment remains non-codified. Methods. This retrospective study was conducted from January 2008 to December 2022 in a single tertiary department exclusively dedicated to lymphatic diseases. All consecutive patients with YNS were included. Results. Thirteen men and 10 women were included in the study. Three patients had yellow nails at birth or during childhood. For the other 20 patients, median (Q1–Q3) age at first sign was 50.8 (43–61) years. Median (Q1–Q3) first-YNS-sign-to-diagnosis interval was 17 (10–56) months. For 4 patients, YNS was associated with primary intestinal lymphangiectasia. The first YNS sign was chronic cough (45.5%), followed by yellow nails (27.3%), chronic sinusitis (18.2%) and lymphedema (9.1%). At first consultation, among these 23 patients, 69.6% had the complete triad, all had yellow nails and cough, 82.6% chronic sinusitis and 69.6% lymphedema. Lymphedema involved only the lower limb (n=12), lower and upper limbs (n=2), the lower and upper limb and face (n=2). Nineteen (82.6%) patients were treated with fluconazole (100 mg/d, (n=8) or 300 mg/wk, (n=11)) combined with vitamin E (1000 mg/d) for a median of 13 months. Responses were complete for 4 (21.1%) patients, partial for 8 (42.1%) and therapeutic failures for 7 (36.8%). Conclusion. YNS is a rare disease that almost always starts with a chronic cough. Despite inconstant efficacy, fluconazole–vitamin E in combination can be prescribed to treat yellow nails.

show abstract